Refractory polymyositis responding to infliximab: extended follow-up.
Labioche
I
I
Liozon
E
E
Weschler
B
B
Loustaud-Ratti
V
V
Soria
P
P
Vidal
E
E
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D017285:Polymyositis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D000069285:Infliximab